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Phosphatidylinositol-4,5-bisphosphate is required for endocytic
coated vesicle formation
Matthias Jost*, Fiona Simpson*, Jennifer M. Kavran†, Mark A. Lemmon†
and Sandra L. Schmid*
Receptor-mediated endocytosis via clathrin-coated
vesicles has been extensively studied and, while many
of the protein players have been identified, much
remains unknown about the regulation of coat
assembly and the mechanisms that drive vesicle
formation [1]. Some components of the endocytic
machinery interact with inositol polyphosphates and
inositol lipids in vitro, implying a role for
phosphatidylinositols in vivo [2,3]. Specifically, the
adaptor protein complex AP2 binds
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2),
PtdIns(3)P, PtdIns(3,4,5)P3 and inositol phosphates.
Phosphatidylinositol binding regulates AP2 self-
assembly and the interactions of AP2 complexes with
clathrin and with peptides containing endocytic motifs
[4,5]. The GTPase dynamin contains a pleckstrin
homology (PH) domain that binds PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 to regulate GTPase activity in vitro [6,7].
However, no direct evidence for the involvement of
phosphatidylinositols in clathrin-mediated endocytosis
exists to date. Using well-characterized PH domains as
high affinity and high specificity probes in combination
with a perforated cell assay that reconstitutes coated
vesicle formation, we provide the first direct evidence
that PtdIns(4,5)P2 is required for both early and late
events in endocytic coated vesicle formation.
Addresses: *Department of Cell Biology, The Scripps Research
Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037. USA.
†Department of Biochemistry and Biophysics, University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Correspondence: Sandra L. Schmid
E-mail: slschmid@scripps.edu
Received: 26 October 1998
Revised: 19 November 1998
Accepted: 20 November 1998
Published: 14 December 1998
Current Biology 1998, 8:1399–1402
http://biomednet.com/elecref/0960982200801399
© Current Biology Ltd ISSN 0960-9822
Results and discussion
To test whether inositol lipids play a direct role in the for-
mation of functionally active coated pits, we investigated
the effect of several phosphatidylinositol-binding probes
in an in vitro assay using perforated A431 cells that faith-
fully reconstitutes receptor-mediated endocytosis [8,9].
This assay measures the cytosol- and ATP-dependent
sequestration of receptor-bound biotinylated transferrin
(BTfn) into coated vesicles and constricted coated pits
(Figure 1). Supplementing this reaction with purified AP2
complexes stimulates the de novo formation of functionally
active coated pits increasing the efficiency of sequestra-
tion of BTfn into constricted coated pits [9]. The differ-
ence between the two curves in Figure 1 (shown in the
inset) provides a selective measure of AP2-dependent
sequestration of BTfn and reflects early events in coated
vesicle formation.
We first examined the effect of the aminoglycoside anti-
biotic neomycin on endocytosis. Neomycin binds
PtdIns(4,5)P2 with reasonably high affinity and specificity
[10]. Addition of neomycin to perforated A431 cells
potently inhibited the sequestration of BTfn measured in
either the presence or absence of supplemental AP2; half-
maximal inhibition required ~120 µM neomycin (see Sup-
plementary material published with this paper on the
internet). In contrast, >300 µM neomycin was required to
half-maximally inhibit AP2 recruitment onto endosomes
[11]. Several controls established the specificity of the
neomycin effect (see Supplementary material). 
To obtain more direct evidence for a specific
PtdIns(4,5)P2 requirement in endocytosis we used differ-
ent PH domains as probes. Many proteins involved in
signal transduction or cytoskeleton function contain a
protein module of about 100 amino acids originally identi-
fied in the protein kinase C substrate, pleckstrin [12].
These PH domains have been well characterized, both
structurally and functionally. They bind phosphoinosi-
tides [12,13] and can be divided into several groups
according to their affinity and specificity for phospho-
inositide binding [14,15]. For this study, we used the fol-
lowing PH domains that represent three distinct groups:
the PH domain of general receptor of phosphoinositides-1
(Grp1) that specifically binds PtdIns(3,4,5)P3 and
Ins(1,3,4,5)P4 with high affinity [15,16]; the PH domain of
phospholipase Cδ (PLCδ) that specifically binds
PtdIns(4,5)P2 and Ins(1,4,5)P3 with high affinity [17]; and
the monomeric PH domains of dynamin-1 and dynamin-2
that bind with low affinity to PtdIns(3,4,5)P3 and
PtdIns(4,5)P2 [7]. These PH domains provide ideal
probes for detecting a specific requirement for phos-
phatidylinositols in endocytosis.
Strikingly, only the PLCδ PH domain (PLCδ-PH) inhib-
ited AP2-stimulated sequestration of BTfn (Figure 2a);
the Grp1, dynamin-1 and dynamin-2 PH domains had no
effect. Interestingly, in contrast to the effects of neomycin
(see Supplementary material), none of the PH domains,
including PLCδ-PH, inhibited the residual BTfn seques-
tration obtained at limiting concentrations of cytosol
(Figure 2a). This signal is believed to derive from the con-
striction of coated pits previously assembled in vivo. The
observed differences in the effects of neomycin and
PLCδ-PH support concerns raised by others regarding the
specificity of neomycin [18,19].
To confirm that inhibition by PLCδ-PH was due to 
its ability to bind PtdIns(4,5)P2 with high affinity, we 
constructed a mutated PLCδ PH domain. Mutations were
introduced at two residues (K32A and W36N) that form
hydrogen bonds with Ins(1,4,5)P3 in the X-ray crystal
structure of the PLCδ-PH–Ins(1,4,5)P3 complex [20].
These mutations effectively abolished binding of both
PtdIns(4,5)P2 and Ins(1,4,5)P3 by PLCδ-PH as assessed
by lipid dot-blots, gel filtration and isothermal calorimetry
binding assays (data not shown). As seen in Figure 2b,
wild-type PLCδ-PH potently inhibited AP2-stimulated
BTfn sequestration, but the mutated PH domain had no
effect, even at the highest concentration tested. Half-
maximal inhibition by wild-type PLCδ-PH occurred at
~3 µM, which is in good agreement with its reported Kd
for binding to PtdIns(4,5)P2 of ~2 µM [17]. These experi-
ments demonstrate the validity of using PH domains for
assessing the role of specific phosphoinositides in mem-
brane trafficking events. Moreover, because PLCδ-PH
inhibited AP2-stimulated BTfn sequestration whereas
Grp1-PH did not, our results provide direct evidence that
PtdIns(4,5)P2, but not PtdIns(3,4,5)P3, is required for
AP2-stimulated early events in coated vesicle formation.
To more specifically identify the PLCδ-PH-sensitive
event in coated vesicle formation, we used a two-staged
assay that measures AP2 recruitment to perforated cell
membranes [9]. Perforated A431 cells were first pre-incu-
bated at 4°C in the presence of buffer, PH domain or AP2.
The membranes were then collected by centrifugation and
subjected to a second incubation, at 37°C, in the presence
of BTfn, limiting cytosol and an ATP-regenerating system,
and in the presence or absence of AP2 and PH domains.
Pre-incubation of membranes with buffer alone had no
effect on the AP2-stimulated BTfn sequestration observed
in the subsequent 37°C incubation (Figure 3, assay 1). In
contrast, when AP2 was included in the 4°C pre-incuba-
tion, the membranes became primed with AP2 complexes
and efficient BTfn sequestration was observed in the sub-
sequent 37°C incubation, even in the absence of supple-
mental AP2 (Figure 3, assay 2). Inclusion of wild-type, but
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Figure 2
PtdIns(4,5)P2 is required for early steps of
endocytosis. (a) Assays were performed as
described in Figure 1 with or without added
AP2 in the presence of the indicated PH
domains (12 µM). (b) AP2-dependent BTfn
sequestration was measured in the presence
of the indicated concentrations of either wild-
type PLCδ-PH or a mutant PLCδ-PH that is
defective in PtdIns(4,5)P2 binding. The results
show the average ± SD from three
experiments. Dyn, dynamin.
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Figure 1
AP2-stimulated transferrin sequestration in perforated cells. BTfn
uptake in perforated A431 cells was measured as described [8,9].
Incubations were performed in the presence of the indicated
concentration of K562 cell cytosol in the presence or absence of
added AP2. The inset shows the AP2-specific stimulation of cytosol-
dependent BTfn sequestration. For subsequent experiments, BTfn
sequestration was measured at 2 mg/ml cytosol which allows for
maximum AP2-dependent stimulation. 
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– added AP2 AP2-dependent signal
not mutated PLCδ-PH in the second incubation abro-
gated this AP2-stimulated BTfn sequestration (Figure 3,
assay 2). These data suggest that prebound AP2 com-
plexes can be displaced by wild-type PLCδ-PH, probably
because it has a higher affinity for PtdIns(4,5)P2 and/or a
lower off-rate compared to AP2. Thus, PLCδ-PH appears
to specifically inhibit the de novo formation of coated pits
that occurs in the presence of supplemental AP2 com-
plexes. Once coats are fully assembled, their association
with the membrane appears to be resistant to disruption
by PLCδ-PH.
Interestingly, pre-incubation of perforated cells with wild-
type PLCδ-PH (Figure 3, assay 3) blocked AP2-stimu-
lated BTfn sequestration in the subsequent incubation at
37°C. Again, the constriction of preformed coated pits,
detected at limiting cytosol concentrations in the absence
of supplemental AP2 complexes, was unaffected. In con-
trast, mutated PLCδ-PH had no such effect (Figure 3,
assay 4). These data exclude the possibility that the PH
domain acts on soluble inositol phosphates, and instead
suggest that the PH domain is recruited to the plasma
membrane, even at 4°C, and prevents subsequent AP2
recruitment. These findings are consistent with previous
studies suggesting that there are discrete AP2 docking
sites on the plasma membrane [21]. Although there is
good evidence that these docking sites are protease sensi-
tive [21], our findings strongly suggest that PtdIns(4,5)P2
is also a necessary component.
We were unable to detect an effect of isolated dynamin
PH domains on endocytosis in vitro presumably because
they have a low affinity for inositol lipids [7,22]. Recent
evidence, however, suggests a role for dynamin–phos-
phatidylinositol interactions in endocytosis in vivo [23].
Dynamin is concentrated at coated pits and is required for
late events in endocytosis leading to the detachment of
clathrin-coated vesicles [1]. We therefore sought evidence
for a requirement for inositol lipids using an assay that
selectively measures late events in endocytosis. Coated
vesicle formation in perforated cells is specifically
detected when receptor-bound transferrin which has been
biotinylated via a cleavable disulfide bond (BSSTfn), is
taken up into sealed vesicles and becomes inaccessible to
the small membrane-impermeant reducing agent, β-mer-
captoethane sulfonate, sodium salt (MesNa) [8,24].
Coated vesicle formation in this assay requires cytosol and
ATP (Figure 4a) and is inhibited by GTPγS [24]. Similarly
to its effect on early events, PLCδ-PH inhibited the late
events in endocytosis that lead to the formation of endo-
cytic coated vesicles (Figure 4). Half-maximal inhibition
required ~5 µM PLCδ-PH (Figure 4b), comparable to the
levels required for inhibition of AP2-dependent BTfn
sequestration. The extent of inhibition appeared to
plateau at ~50%, perhaps reflecting an inability of PLCδ-
PH to interfere with the substantial membrane-bound
pool of dynamin known to be concentrated at coated pits.
Importantly, other PH domains had no effect (Figure 4a),
nor had the mutated PLCδ-PH (Figure 4b), confirming
that the observed inhibition was due to the ability of wild-
type PLCδ-PH to bind PtdIns(4,5)P2.
The use of PH domains with well-characterized binding
affinities and specificities for distinct phosphatidylinosi-
tols has provided the first direct evidence that
PtdIns(4,5)P2 is specifically required for early events in
clathrin-mediated endocytosis leading to coat assembly
and for late events leading to coated vesicle detachment.
These steps correspond to those requiring AP2 and
dynamin, respectively, and our results are consistent with
observations that both proteins bind phosphatidylinosi-
tols. Moreover, our data suggest that a tighter specificity of
lipid interactions exists in the functional context of coated
vesicle formation than has been reported for the interac-
tions of these proteins with phosphatidylinositols in vitro.
A specific requirement for PtdIns(4,5)P2 in endocytic
coated vesicle formation, as opposed to phosphatidylinosi-
tols phosphorylated in the D-3 position, is consistent with
the observation that concentrations of wortmannin suffi-
cient to inhibit PtdIns 3-kinases (25 nM) stimulate the
rate of transferrin internalization in vivo [25]. ATP hydrol-
ysis is known to be required for both coat assembly and
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Figure 3
A staged assay reveals that wild-type PLCδ-PH inhibits coat formation
by competing with AP2 for the same membrane-docking site.
Perforated A431 cells were pre-incubated at 4°C under four different
conditions: assay 1, with buffer alone; assay 2, with AP2 (100 µg/ml);
assay 3, with wild-type (WT) PLCδ-PH; and assay 4, with mutant
PLCδ-PH. Membranes were collected by brief centrifugation,
resuspended, and incubated under normal assay conditions at 37°C in
the presence or absence of added AP2 or PH domains as indicated.
The results show the average ± SD from three experiments.
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vesicle budding in vitro [8]. Whether this requirement
reflects the involvement of lipid kinases needed to gener-
ate PtdIns(4,5)P2 remains to be established.
Supplementary material
A figure showing the inhibition of BTfn sequestration by neomycin
and additional methodological details are published with this paper
on the internet.
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Figure 4
Coated vesicle formation is specifically
inhibited by PLCδ-PH. Coated vesicle
formation in perforated 3T3L1 cells was
detected when receptor-bound BSSTfn
became inaccessible to MesNa. (a) Coated
vesicle formation was dependent on the
presence of both ATP and cytosol and was
not affected by the addition of 30 µM Grp1,
dynamin-1 (dyn1) or dynamin-2 (dyn2) PH
domains, as indicated. Inclusion of PLCδ-PH
inhibited coated vesicle formation by ~50%. A
representative result from three experiments is
shown. (b) Coated vesicle formation was
measured in the presence of the indicated
concentrations of either wild-type or mutant
PLCδ-PH. The results show the average ± SD
from three experiments.
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Supplementary materials and methods
Perforated cell assays for endocytic coated vesicle formation
The in vitro internalization assay using perforated A431 cells was
essentially performed as described [S1–S3] with a few modifications
to increase the consistency of the results as detailed below. Perfo-
rated A431 cells were pooled from 10 culture dishes (150 × 25 mm)
and stored at –70°C in ten 80 µl aliquots in 0.75 M sucrose, 5 mM
MgCl2, 25 mM Hepes-KOH, pH 7.4. One aliquot, resuspended in
300 ml KSHM (100 mM K-acetate, 85 mM sucrose, 1 mM Mg-
acetate, and 20 mM Hepes-KOH, pH 7.4) was sufficient for 35 in
vitro assay reactions. Cytosol was prepared from K562 cells as
described [S3] with the exception that the cells were homogenized by
N2-cavitation bomb at 500 psi for 20 min in KSHM including Com-
plete protease cocktail (Boehringer Mannheim). Internalization assays
were performed at limiting cytosol concentrations (2 mg/ml) in the
presence or absence of 100 µg/ml AP2. Incubation time was 20 min
at 37°C. AP2 complexes were purified after extraction from a micro-
somal pellet as described [S3] and stored at –70°C in KHM (KSHM
without sucrose).
For AP2 priming experiments, perforated A431 cells were preincu-
bated in KSHM + 0.5% BSA with either no addition, AP2 (100 µg/ml),
or wild-type or mutant PLCδ-PH (6 mM each) for 15 min at 4°C as indi-
cated in Figure 3. Subsequently cells were sedimented (5 sec,
14000 × g, 4°C, Eppendorf microfuge) and reincubated at 37°C under
standard assay conditions including an ATP-regenerating system,
cytosol and AP2 or the PLCδ-PH domains [S3].
The MesNa assay was carried out as previously described [S1,S2] with
the following modifications. 3T3L1 undifferentiated adipocytes (kindly
provided by S. van Delft and A.J. Verkleij, Utrecht) were permeabilized
after washing in KSHM by freezing a culture dish (150× 25 mm) in liquid
N2 and rapid thawing at 37°C. Cytosol was prepared from frozen rat
brains (Pelfreez) as previously described [S1]. Perforated cells, recov-
ered by scraping and low speed sedimentation, were preincubated with
BSSTfn for 15 min at 4°C prior to the addition of other reagents.
Specificity controls for neomycin effects
As controls for the specificity of neomycin, we tested several related
aminoglycoside compounds (kindly provided by W. Greenberg and
C.-H. Wong), not known to bind PtdIns(4,5)P2. These included: 2-des-
oxystreptamin, a neomycin derivative with one amino-sugar that con-
tains two instead of six primary amino-groups; neamine, a neomycin
derivative with two O-linked amino-sugars; and the neomycin-related
antibiotics gentamycin and kanamycin that have four instead of six
primary amino groups. None of these compounds detectably inhibited
cytosol-dependent or AP2-stimulated BTfn sequestration, even when
tested at 500 µM (data not shown). Thus, the inhibitory effect of
neomycin on the formation of constricted coated pits was most likely
due to its ability to bind PtdIns(4,5)P2.
We also controlled for other nonspecific effects of neomycin that might
be due to its polycationic character and resulting nonspecific interac-
tions with a variety of anionic proteins, as seen in other studies [S4]. As
a control for nonspecific neomycin-induced protein aggregation,
cytosol was preincubated with or without 600 µM neomycin for 15 min
at 4°C and then subjected to centrifugation (to pellet aggregated pro-
teins) and gel filtration (to remove added neomycin). There was no dif-
ference in the ability of the neomycin pretreated cytosol to support
BTfn sequestration in perforated cells as compared to control cytosol
(data not shown). 
Preparation and characterization of wild-type and mutant PH
domains
All PH domains were produced as soluble proteins in Escherichia coli
BL21-DE3 by expression from pET11a at 37°C. The dynamin-1 and
dynamin-2 PH domains were produced as described [S5]. The PLCδ-
PH (wild-type and mutant) were produced as described [S6,S7]. The
Grp1 PH domain was produced as described [S8]. All proteins were at
least 95% pure as assessed by overloaded Coomassie-blue-stained
SDS–PAGE.
Residues K32 and W36 in rat PLCδ-PH were mutated to Ala (A) and
Asn (N) respectively using a standard four-primer PCR method; the
sequence was confirmed, and protein was purified as described for
wild-type PLCδ-PH [S7]. Whereas strong binding of wild-type PLCδ-
PH to PtdIns(4,5)P2 and Ins(1,4,5)P3 is seen in a lipid dot-blot assay
[S7] and by gel-filtration with [3H]Ins(1,4,5)P3 [S6], respectively, the
mutated PLCδ-PH gave no binding signal in either assay (J.M.K. and
M.A.L.,  unpublished observations). Using isothermal titration calorime-
try [S6], the mutations were found to increase the Kd for Ins(1,4,5)P3
binding from 0.21 µM (wild-type) to significantly more than 10 µM
(K32A/W36N), indicating that the mutated PH domain binds
Ins(1,4,5)P3 and PtdIns(4,5)P2 >50-fold more weakly than wild-type
PLCδ-PH (data not shown).
Supplementary material
Figure S1
AP2-stimulated transferrin sequestration in perforated cells is
inhibited by neomycin. Addition of neomycin, at the concentrations
indicated, inhibited cytosol-dependent BTfn sequestration assayed in
either the presence or absence of added AP2. The inset shows the
extent of neomycin inhibition expressed as a percentage of the
control. The results show the average ± SD from three experiments.
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